Policy breakthrough: out-of-pocket influenza vaccines may now be covered by medical insurance, potentially boosting vaccination willingness and creating a stimulative effect.
① The policy may directly boost vaccination willingness, particularly exerting a positive pull effect among working populations and elderly individuals and children covered under family mutual aid schemes; ② Given the current industry supply-demand dynamics, the prevailing low-price competition in the influenza vaccine market is unlikely to reverse in the short term. However, as vaccine manufacturers continue public education campaigns that raise public awareness and vaccination intent—combined with steadily expanding payment channels for vaccines—the industry’s operating conditions are expected to gradually stabilize.
Ellis Shareholders' Meeting: Heavy reliance on a single blockbuster product, with more growth anxieties to address amid the looming patent cliff.
① Once the growth dividend of Fumetinib begins to taper off, whether there will be a successor product and where Alis's "next Fumetinib" lies have become key focal points for the market; ② The domestic patent for the Fumetinib compound is set to expire in 2034, while the domestic patent for Methanesulfonic Acid Fumetinib (salt) will expire in 2036. **This implies that the existing patent protection barrier will vanish by then, and Alis may no longer enjoy the high gross profit margin associated with its original drug.**
Hot Semiconductor Stock Jumps 30% in Three Days; Company Clarifies No Direct Business Ties with Samsung | Selected Post-Market Announcements
A popular semiconductor material stock explicitly stated that it has no direct business relations with Samsung. A chemical giant announced an ambitious expansion plan, while a company’s annual report was unanimously rejected by its own audit committee...
Express News | Wuxi Apptec: Plans to Issue Zero-Coupon Convertible Bonds Settled in US Dollars with a Value of RMB 6.78 Billion Maturing in 2027
Optical Fiber Bull Stock Clarification: The Company Has No Business Relationship with NVIDIA! | After-Hours Announcement Highlights
Optical fiber stock urgently clarifies no connection with NVIDIA! Stock with five limit-up days in seven trading sessions issues risk warning; pharmaceutical giant announces its holding subsidiary has signed an exclusive option agreement.
No business relationship with NVIDIA whatsoever! A 33 billion yuan fiber-optic concept stock releases clarification announcement | Post-market announcements summary
China Jushi: Plans to invest 4.431 billion yuan in building a production line project for 50,000 tons of electronic yarn and 320 million meters of electronic cloth annually